ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,852Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 823

$821K Total Retail Price of All Prescriptions

Rank: 36 out of 823

467 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 467 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

0% of this provider’s 13,513 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
CARVEDILOL 793 742 1 12
POTASSIUM CHLORIDE 706 646 2 22
LEVOTHYROXINE SODIUM 601 594 3 6
METOPROLOL SUCCINATE 579 549 4 9
RAMIPRIL 474 429 5 69
CRESTOR 468 427 6 20
LOSARTAN POTASSIUM 458 448 7 26
WARFARIN SODIUM 445 432 8 18
AMLODIPINE BESYLATE 429 379 9 3
PRAVASTATIN SODIUM 418 359 10 23
FUROSEMIDE 360 321 11 7
OMEPRAZOLE 326 310 12 5
METOPROLOL TARTRATE 314 288 13 11
METFORMIN HCL 297 268 14 14
ATORVASTATIN CALCIUM 263 254 15 13
DIGOXIN 263 238 15 33
SPIRONOLACTONE 261 250 17 72
LISINOPRIL 261 238 17 4
HYDROCODONE-ACETAMINOPHEN 254 225 S3 19 1
SIMVASTATIN 237 224 20 2
GABAPENTIN 233 183 21 8
ISOSORBIDE MONONITRATE ER 217 197 22 49
LOSARTAN-HYDROCHLOROTHIAZIDE 216 206 23 57
CLOPIDOGREL 214 194 24 16
PANTOPRAZOLE SODIUM 200 200 25 30
DIOVAN 195 195 26 35
PLAVIX 177 160 27 25
TORSEMIDE 163 153 28 161
HYDROCHLOROTHIAZIDE 158 122 29 29
PRADAXA 152 152 30 179
CITALOPRAM HBR 147 129 31 34
RANEXA 134 109 32 149
LANTUS 129 115 33 76
NATEGLINIDE 115 95 34 289
DONEPEZIL HCL 112 112 35 24
MULTAQ 109 99 36 245
AMIODARONE HCL 104 104 37 106
ALLOPURINOL 95 82 38 61
NEXIUM 89 76 39 10
GLIMEPIRIDE 80 67 40 51
CLONIDINE HCL 77 65 41 41
BYSTOLIC 75 65 42 98
ADVAIR DISKUS 73 72 43 68
KLOR-CON M10 71 47 44 182
CYMBALTA 70 69 45 40
NAMENDA 66 66 46 28
TEKTURNA 64 64 47 373
ISRADIPINE 63 54 10 48 474
KLOR-CON 10 62 49 49 398
ENALAPRIL MALEATE 56 46 50 62
AZITHROMYCIN 55 48 51 48
PACERONE 53 53 52 351
ESCITALOPRAM OXALATE 52 40 53 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.